Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

Clinical trial NCT00112502 · COMPLETED

Trial details

NCT number: NCT00112502
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Glioblastoma Multiforme

Start date: 2005-09-01
Primary completion: 2014-09-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.